FDA Consumer Advice on Pet Exposure to Prescription Topical Pain Medications Containing Flurbiprofen
Key Advice |
The U.S. Food and Drug Administration is alerting pet owners who use prescription topical pain medications containing flurbiprofen to use care when using them in a household with pets. Pets are at risk of illness and death when exposed to certain pain medications applied to the skin of their owners. Even very small amounts of flurbiprofen, such as a slight amount left on a cloth applicator, could be dangerous to pets. This advice follows reports made to the FDA of cats in two households that became ill or died after their owners used prescription-strength topical medications containing flurbiprofen on themselves to treat muscle, joint, or other pain. The pet owners had applied the cream or lotion to their own neck or feet, and not directly to the pet, and it is not known exactly how the cats became exposed to the medication. The products contained the flurbiprofen and the muscle relaxer cyclobenzaprine, as well as other varying active ingredients, including baclofen, gabapentin, lidocaine, or prilocaine. Flurbiprofen is a non-steroidal anti-inflammatory drug (NSAID). |
Who should know |
Pet owners who use topical pain medications containing flurbiprofen. |
What to do |
|
Why this advice is important |
Even very small exposure to flurbiprofen can be potentially life-threatening to pets. |